Olivia Campagne

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study

Jason Fangusaro, Arzu Onar‐Thomas, Tina Young Poussaint et al. · Neuro-Oncology · 2021 · 147 citations · Full text

A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies

Sara M. Federico, Alberto S. Pappo, Natasha Sahr et al. · European Journal of Cancer · 2020 · 67 citations

Young Adults, Oncology, Refractory Solid Malignancies +6

Integrated Pharmacokinetic/Pharmacodynamic Model of a Bispecific CD3xCD123 DART Molecule in Nonhuman Primates: Evaluation of Activity and Impact of Immunogenicity

Olivia Campagne, Audrey Delmas, Sylvain Fouliard et al. · Clinical Cancer Research · 2018 · 58 citations · Full text

Tacrolimus Population Pharmacokinetics and Multiple<i>CYP3A5</i>Genotypes in Black and White Renal Transplant Recipients

Olivia Campagne, Donald E. Mager, Daniel A. Brazeau et al. · The Journal of Clinical Pharmacology · 2018 · 45 citations

A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042)

David Van Mater, Sridharan Gururangan, Oren J. Becher et al. · Pediatric Blood & Cancer · 2021 · 42 citations · Full text